Title:
KIF18A INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2024/067465
Kind Code:
A1
Abstract:
Provided are a compound useful as a KIF18A inhibitor, a pharmaceutically acceptable salt, an ester or a stereoisomer thereof, a pharmaceutical composition and a preparation comprising the compound or the pharmaceutically acceptable salt, the ester or the stereoisomer thereof, a preparation method for the compound or the pharmaceutically acceptable salt, the ester or the stereoisomer thereof, and use of the compound or the pharmaceutically acceptable salt, the ester or the stereoisomer thereof in the preparation of a drug for treating and/or preventing a KIF18A-mediated disease and related diseases.
Inventors:
LIU BIN (CN)
GUO DONGMAN (CN)
GUO DONGMAN (CN)
Application Number:
PCT/CN2023/121036
Publication Date:
April 04, 2024
Filing Date:
September 25, 2023
Export Citation:
Assignee:
SHANDONG XUANZHU PHARMA CO LTD (CN)
International Classes:
C07D471/04; A61K31/438; A61P35/00; C07D471/14; C07D487/04; C07D498/14
Domestic Patent References:
| WO2023174175A1 | 2023-09-21 |
Foreign References:
| CN114302880A | 2022-04-08 | |||
| CN114391012A | 2022-04-22 | |||
| CN113226473A | 2021-08-06 |
Download PDF: